FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marie-Anne Loriot

Research Profile

Physiology

Chemicals & Drugs

Concepts & Ideas

Procedures

Occupations

Pharmacogenetics

Geographic Areas

France

Genes & Molecular Sequences

Co-author Network

Publications

TOP 3
Caroline Moreau; Marie-Anne Loriot; Virginie Siguret
[Vitamin K antagonists: from discovery to pharmacogenetics].
Ismaïl Ahmed; Philippe Beaune; Dominique Charron; Marc Delord; Rajagopal Krishnamoorthy; Jean-Charles Lambert; Pierre Laurent-Puig; Marie-Anne Loriot; Claire Mulot; Magali Nacfer; Ryad Tamouza; Christophe Tzourio; Alexis Elbaz
Association between Parkinson's disease and the HLA-DRB1 locus.
Caroline Moreau; Virginie Siguret; Fanny Bajolle; Philippe Beaune; Damien Bonnet; Radhia Cheurfi; Caroline Elie; Jean-Louis Golmard; Dominique Lasne; Marie-Anne Loriot
Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marie-Anne Loriot (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Caroline Moreau; Marie-Anne Loriot; Virginie Siguret
[Vitamin K antagonists: from discovery to pharmacogenetics].
Annales de biologie clinique 2012;70(5):539-51.
2012: Ismaïl Ahmed; Philippe Beaune; Dominique Charron; Marc Delord; Rajagopal Krishnamoorthy; Jean-Charles Lambert; Pierre Laurent-Puig; Marie-Anne Loriot; Claire Mulot; Magali Nacfer; Ryad Tamouza; Christophe Tzourio; Alexis Elbaz
Association between Parkinson's disease and the HLA-DRB1 locus.
Movement disorders : official journal of the Movement Disorder Society 2012;27(9):1104-10.
2012: Caroline Moreau; Virginie Siguret; Fanny Bajolle; Philippe Beaune; Damien Bonnet; Radhia Cheurfi; Caroline Elie; Jean-Louis Golmard; Dominique Lasne; Marie-Anne Loriot
Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement.
Blood 2012;119(3):861-7.
2011: Jean Szymezak; Caroline Moreau; Marie-Anne Loriot; Eric Durand; Hubert Van Viet; Michel Desnos; Pascale Gaussem
High on-clopidogrel platelet reactivity: genotyping can help to optimize antiplatelet treatment.
Thrombosis research 2011;128(1):92-5.
2011: C Moreau; Eric Pautas; Isabelle Gouin-Thibault; Jean-Louis Golmard; I Mahé; C Mulot; Marie-Anne Loriot; Virginie Siguret
Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypes.
Journal of thrombosis and haemostasis : JTH 2011;9(4):711-8.
2011: Maud Berge; Romain Guillemain; David A Trégouet; Catherine Amrein; Veronique Boussaud; Patrick Chevalier; Agnes Lillo-Lelouet; Christine Le Beller; Pierre Laurent-Puig; Philippe H Beaune; EM Billaud; Marie-Anne Loriot
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients.
European journal of clinical pharmacology 2011;67(3):253-60.
2010: Fabien Dutheil; Aude Jacob; Sandrine Dauchy; Philippe Beaune; Jean-Michel Scherrmann; Xavier Declèves; Marie-Anne Loriot
ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders.
Expert opinion on drug metabolism & toxicology 2010;6(10):1161-74.
2010: Fabien Dutheil; Philippe Beaune; Christophe Tzourio; Marie-Anne Loriot; Alexis Elbaz
Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson disease.
Archives of neurology 2010;67(6):739-45.
2010: Eric Pautas; C Moreau; Isabelle Gouin-Thibault; Jean-Louis Golmard; I Mahé; Christophe Legendre; E Taillandier-Hériche; B Durand-Gasselin; Anne-Marie Houllier; P Verrier; Philippe Beaune; Marie-Anne Loriot; Virginie Siguret
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients.
Clinical pharmacology and therapeutics 2010;87(1):57-64.
2009: Fabien Dutheil; Sandrine Dauchy; Monique Diry; Véronique Sazdovitch; Olivier Cloarec; Lucille Mellottée; Ivan Bièche; Magnus Ingelman-Sundberg; Jean-Pierre Flinois; Isabelle de Waziers; Philippe Beaune; Xavier Declèves; Charles Duyckaerts; Marie-Anne Loriot
Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function.
Drug metabolism and disposition: the biological fate of chemicals 2009;37(7):1528-38.
2008: Pierre Laurent-Puig; Astrid Lièvre; Michel Ducreux; Marie-Anne Loriot
[The biological point of view on pharmacogenetics of anticancer agents in colorectal cancer].
Bulletin du cancer 2008;95(10):935-42.
2008: David M Smadja; Marie-Anne Loriot; Lucia A Hindorff; Lucille Mellottee; Pascale Gaussem; Joseph Emmerich
No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease.
Thrombosis and haemostasis 2008;99(5):970-2.
2008: Jean-François Alexandra; Eric Pautas; Isabelle Gouin-Thibault; Virginie Siguret; Marie-Anne Loriot
Overanticoagulation with coumarin and cutaneous azole therapy.
Annals of internal medicine 2008;148(8):633-5.
2008: Fabien Dutheil; Philippe Beaune; Marie-Anne Loriot
Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain.
Biochimie 2008;90(3):426-36.
2008: Jean-François Ferrand; Sylvie Cénée; Pierre Laurent-Puig; Marie-Anne Loriot; Jean-Claude Trinchet; Françoise Degos; Jean-Pierre Bronovicky; Gilles Pelletier; Isabelle Stücker
Hepatocellular carcinoma and occupation in men: a case-control study.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2008;50(2):212-20.
2008: Eve Maubec; Pierre Wolkenstein; Marie-Anne Loriot; Janine Wechsler; Claire Mulot; Philippe Beaune; Jean Revuz; Jean-Claude Roujeau
Minocycline-induced DRESS: evidence for accumulation of the culprit drug.
Dermatology (Basel, Switzerland) 2008;216(3):200-4.
2007: Delphine Allorge; Philippe Beaune; L Becquemont; G Bessard; S Bezieau; Michèle Boisdron-Celle; J-C Boyer; Franck Broly; C-M Dhaneens; X Fonrose; M-C Gagnieu; Erick Gamelin; C Gozé; E Jacqz-Aigrain; S Loric; Marie-Anne Loriot; P Marquet; A Morel; B Namour; G Paintaud; K Peoc'h; N Picard; Hervé Watier; Céline Verstuyft
[Molecular pharmacogenetics in hospital laboratories in France: current data and future prospects].
Annales pharmaceutiques françaises 2007;65(6):371-81.
2007: Marie-Anne Loriot; Philippe Beaune
[Pharmacogenetics of oral anticoagulants: individualized drug treatment for more efficacy and safety].
La Revue du praticien 2007;57(12):1281-6.
2007: Isabelle Stücker; Marie-Anne Loriot; G N'koutchou; Sylvie Cénée; L Bodin; C Mulot; M Gelu-Simeon; L Pelletier; J P Bronowicki; Françoise Degos; Philippe Beaune; Pierre Laurent-Puig; Denis Hémon; J C Trinchet; G Pelletier
UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers?
BMC cancer 2007;7():214.
2007: Fady Daniel; Marie-Anne Loriot; Philippe Seksik; Jacques Cosnes; Jean-Marc Gornet; Marc Lémann; Francine Fein; Gwenola Vernier-Massouille; Martine De Vos; Arnaud Boureille; Xavier Treton; Bernard Flourié; Xavier Roblin; Edouard Louis; Frank Zerbib; Philippe Beaune; Philippe Marteau
Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.
Inflammatory bowel diseases 2007;13(1):19-23.
2006: Isabelle Chevrier; David-Alexandre Tregouet; Simone Massonnet-Castel; Philippe Beaune; Marie-Anne Loriot
Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?
Atherosclerosis 2006;188(1):150-4.
2006: Thierry Lecomte; Bruno Landi; Philippe Beaune; Pierre Laurent-Puig; Marie-Anne Loriot
Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3050-6.
2006: Gisèle Pickering; Marie-Anne Loriot; Frédéric Libert; Alain Eschalier; Philippe Beaune; Claude Dubray
Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism.
Clinical pharmacology and therapeutics 2006;79(4):371-8.
2006: Céline Moreau; Dominique Debray; Marie-Anne Loriot; Anne-Marie Taburet; Valérie Furlan
Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient.
Transplantation 2006;81(3):487-8.
2005: Jacqueline Clavel; Stéphanie Bellec; Sandra Rebouissou; Florence Ménégaux; Jean Feunteun; Catherine Bonaïti-Pellié; André Baruchel; Kamila Kebaili; Anne Lambilliotte; Guy Leverger; Danièle Sommelet; Brigitte Lescoeur; Philippe Beaune; Denis Hémon; Marie-Anne Loriot
Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2005;14(6):531-40.
2005: Pierre Wolkenstein; Marie-Anne Loriot; Antoine Flahault; Michel Cadilhac; Eric Caumes; Muriel Eliaszewicz; Philippe Beaune; Jean-Claude Roujeau; Olivier Chosidow
Association analysis of drug metabolizing enzyme gene polymorphisms in AIDS patients with cutaneous reactions to sulfonamides.
The Journal of investigative dermatology 2005;125(5):1080-2.
2005: Laurent Bodin; Céline Verstuyft; David-Alexandre Tregouet; Annie Robert; Liliane Dubert; Christian Funck-Brentano; Patrice Jaillon; Philippe Beaune; Pierre Laurent-Puig; Laurent Becquemont; Marie-Anne Loriot
Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.
Blood 2005;106(1):135-40.
2005: Claire Mulot; Isabelle Stücker; Jacqueline Clavel; Philippe Beaune; Marie-Anne Loriot
Collection of human genomic DNA from buccal cells for genetics studies: comparison between cytobrush, mouthwash, and treated card.
Journal of biomedicine & biotechnology 2005;2005(3):291-6.
2005: Laurent Bodin; Philippe H Beaune; Marie-Anne Loriot
Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real-time quantitative PCR.
Journal of biomedicine & biotechnology 2005;2005(3):248-53.
2004: Thierry Lecomte; Jean-Marc Ferraz; Franck Zinzindohoué; Marie-Anne Loriot; David-Alexandre Tregouet; Bruno Landi; Anne Berger; Paul-Henri Cugnenc; Raymond Jian; Philippe Beaune; Pierre Laurent-Puig
Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5880-8.
2004: Delphine Allorge; Marie-Anne Loriot
[Pharmacogenetics or the promise of a personalized medicine: variability in drug metabolism and transport].
Annales de biologie clinique 2004;62(5):499-511.
2004: Jean-Marc Ferraz; Franck Zinzindohoué; Thierry Lecomte; Paul-Henri Cugnenc; Marie-Anne Loriot; Philippe Beaune; Isabelle Stücker; Anne Berger; Pierre Laurent-Puig
Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer.
International journal of cancer. Journal international du cancer 2004;110(2):183-7.
2004: Marie-Anne Loriot; Philippe Beaune
[Pharmacogenomics: the link between genes and response to drugs].
Médecine sciences : M/S 2004;20(6-7):634-6.
2004: Franck Zinzindohoué; Hélène Blons; Stéphane Hans; Marie-Anne Loriot; Anne-Marie Houllier; Daniel Brasnu; Ollivier Laccourreye; David-Alexandre Tregouet; Isabelle Stucker; Pierre Laurent-Puig
Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
Anticancer research 2004;24(3b):2021-6.
2004: Sandrine Morin; Laurent Bodin; Marie-Anne Loriot; Henk H W Thijssen; Annie Robert; Soraya Strabach; Céline Verstuyft; David-Alexandre Tregouet; Liliane Dubert; Pierre Laurent-Puig; Christian Funck-Brentano; Patrice Jaillon; Philippe Beaune; Laurent Becquemont
Pharmacogenetics of acenocoumarol pharmacodynamics.
Clinical pharmacology and therapeutics 2004;75(5):403-14.
2003: Isabelle Chevrier; Isabelle Stücker; Anne-Marie Houllier; Sylvie Cenée; Philippe Beaune; Pierre Laurent-Puig; Marie-Anne Loriot
Myeloperoxidase: new polymorphisms and relation with lung cancer risk.
Pharmacogenetics 2003;13(12):729-39.
2003: Céline Verstuyft; Sandrine Morin; J Yang; Marie-Anne Loriot; Véronique Barbu; Reinhold Kerb; Ulrich Brinkmann; Philippe Beaune; Patrice Jaillon; Laurent Becquemont
[A new, rapid and robust genotyping method for CYP2C9 and MDR1].
Annales de biologie clinique 2003;61(3):305-9.
2003: Céline Verstuyft; Annie Robert; Sandrine Morin; Marie-Anne Loriot; A Flahault; Philippe Beaune; Christian Funck-Brentano; Patrice Jaillon; Laurent Becquemont
Genetic and environmental risk factors for oral anticoagulant overdose.
European journal of clinical pharmacology 2003;58(11):739-45.
2002: Isabelle Stücker; Ari Hirvonen; Isabelle de Waziers; Arnauld Cabelguenne; Katja Metsola; Sylvie Cénée; Elisabeth Koum-Besson; Denis Hémon; Philippe Beaune; Marie-Anne Loriot
Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility.
Carcinogenesis 2002;23(9):1475-81.
2002: Dany Anglicheau; Sylvia Sanquer; Marie-Anne Loriot; Philippe Beaune; Eric Thervet
Thiopurine methyltransferase activity: new conditions for reversed-phase high-performance liquid chromatographic assay without extraction and genotypic-phenotypic correlation.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2002;773(2):119-27.
2001: Céline Verstuyft; Sandrine Morin; Annie Robert; Marie-Anne Loriot; Philippe Beaune; Patrice Jaillon; Laurent Becquemont
Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizers.
Pharmacogenetics 2001;11(8):735-7.
2001: Arnauld Cabelguenne; Marie-Anne Loriot; I Stucker; Hélène Blons; E Koum-Besson; Daniel Brasnu; Philippe Beaune; Ollivier Laccourreye; Pierre Laurent-Puig; Isabelle de Waziers
Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy.
International journal of cancer. Journal international du cancer 2001;93(5):725-30.
2001: Marie-Anne Loriot; S Rebuissou; Mikael Oscarson; Sylvie Cenée; M Miyamoto; Noritaka Ariyoshi; Tetsuya Kamataki; Denis Hémon; Philippe Beaune; Isabelle Stücker
Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population.
Pharmacogenetics 2001;11(1):39-44.
2001: Sandrine Morin; Marie-Anne Loriot; Jean-Marie Poirier; L Tenneze; Philippe Beaune; Christian Funck-Brentano; Patrice Jaillon; Laurent Becquemont
Is diclofenac a valuable CYP2C9 probe in humans?
European journal of clinical pharmacology 2001;56(11):793-7.
2000: P Wolkenstein; Marie-Anne Loriot; S Aractingi; Arnauld Cabelguenne; Philippe Beaune; O Chosidow
Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS.
Pharmacogenetics 2000;10(9):821-8.
2000: Noritaka Ariyoshi; Yoshiki Takahashi; M Miyamoto; Yuri Umetsu; Satoshi Daigo; T Tateishi; S Kobayashi; Y Mizorogi; Marie-Anne Loriot; Isabelle Stücker; Philippe Beaune; M Kinoshita; Tetsuya Kamataki
Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C.
Pharmacogenetics 2000;10(8):687-93.